Prevalence of Food Allergies to Proteins From Different Legumes
1 other identifier
observational
183
1 country
1
Brief Summary
The objective of the study is to assess the prevalence of a sensitization to proteins from legumes by skin prick test using commercial extracts (peanut, soy, and pea) and raw material (lupin) in atopic and healthy subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2012
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 12, 2012
CompletedFirst Posted
Study publicly available on registry
November 16, 2012
CompletedStudy Start
First participant enrolled
December 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedFebruary 4, 2014
February 1, 2014
7 months
November 12, 2012
February 3, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evidence of a sensitization to legume proteins
Evidence of a sensitization to one or more legume proteins (lupin, peanut, soy, and pea)
20 minutes after skin prick
Study Arms (2)
Atopic
Subjects with either documented allergy, neurodermatitis, allergic asthma, allergic rhinitis, and/or a positive atopic score based on the criteria of Erlangen (\>10 points).
Non-atopic
Subjects without atopy.
Eligibility Criteria
Male and female subjects. Age: 18 to 75 years. Subjects with Atopy or non-atopic subjects.
You may qualify if:
- Male and female subjects
- Age 18 up to 75 years
- For group "Atopic": either documented allergy, neurodermatitis, allergic asthma, allergic rhinitis, and/or a positive atopic score based on the criteria of Erlangen (\>10 points).
You may not qualify if:
- Intake of antihistamines, tricyclic antidepressants, systemic corticosteroids
- Acute allergic symptoms
- Skin infections at the test side
- Pregnancy, lactation
- Acute inflammatory diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Jenalead
- SRH Wald-Klinikum Gera GmbHcollaborator
- German Federal Ministry of Education and Researchcollaborator
Study Sites (1)
SRH Wald-Klinikum Gera gGmbH
Gera, Thuringia, 07548, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Martin Kaatz, Dr. med.
SRH Wald-Klinikum Gera GmbH
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. habil.
Study Record Dates
First Submitted
November 12, 2012
First Posted
November 16, 2012
Study Start
December 1, 2012
Primary Completion
July 1, 2013
Study Completion
December 1, 2013
Last Updated
February 4, 2014
Record last verified: 2014-02